Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

119.58
Delayed Data
As of Sep 02
 +4.12 / +3.57%
Today’s Change
83.16
Today|||52-Week Range
140.72
+6.90%
Year-to-Date

Today’s Trading

Previous close115.46
Today’s open117.27
Day’s range115.71 - 119.60
Volume5,510,688
Average volume (3 months)4,908,470
Market cap$91.3B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.25%
Earnings growth (next 5 years)+24.13%
Revenue growth (last year)+17.89%
P/E ratio45.3
Price/Sales12.24
Price/Book14.16

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+2.01+2.52%
GSKGlaxoSmithKline+1.17+2.96%
BMYBristol-Myers Squibb+1.41+2.42%
ABBVAbbVie+0.48+0.79%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.21
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers